drugset / Trial / NCT06765265

Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

NCT06765265

Phase 4 Recruiting 152 enrolled King Edward Medical University
RandomizedParallel-groupOpen-labelSupportive care

Summary

there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 months

Timeline

Start
2025-01-05
Primary completion
2026-01-01
Completion
2026-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg
Subject Rosuvastatin Small molecule 20 mg